Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:10PM EDT. Market open.
| Previous Close | 1.7200 |
| Open | 1.7200 |
| Bid | 1.7800 x 200 |
| Ask | 1.7900 x 1000 |
| Day's Range | 1.6700 - 1.8999 |
| 52 Week Range | 1.2500 - 14.5500 |
| Volume | |
| Avg. Volume | 10,412,151 |
| Market Cap | 484.771M |
| Beta (5Y Monthly) | 1.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2100 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.00 |
GuruFocus.comPacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ...
Detailed Analysis of PACB's Financial Performance and Strategic Adjustments
ZacksPacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
ZacksPacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
© 2024 Yahoo. All rights reserved.